Rare
lephants
Screener
Toggle theme
Nektar Therapeutics
NKTR
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2018
FY2009
Total Cash from Operations:
$43.3M
Line Item
Value
% of Total
Capital Expenditures
$16.4M
37.9%
Other Investing
$26.9M
62.1%
Net Cash Flow
$0
0.0%
Download CSV
